Business
Deals, funding, earnings and the companies behind medical technology.
Boston Scientific Cuts 2026 Guidance for a Third Time After Cyberattack
Third-quarter sales grew 1.5% as the cyberattack and declines in Watchman and electrophysiology weighed on results, and the company now expects fourth-quarter sales to fall.
Latest Across Health Sense
CereVasc Alzheimer's Study Shows How an Investigational Device Exemption Works
Cooper Companies CEO Albert White Steps Down; Rosebrough Named Executive Chair
FDA Early Alert Covers All Medline Beds After Two Deaths and Market Exit
FDA Expands Instylla's Embrace Hydrogel Embolic Approval to Peripheral Arterial Bleeds
Heat Packs and Heating Pads Make Up 83% of FDA Reports on Physical Therapy Devices
More in Business
RadNet Agrees to Acquire Teleradiology Provider ONRAD for $350 Million Plus Stock
The outpatient imaging operator would add hospital radiology staffing and remote reads as a third business segment, with an earnout worth up to $210 million.
Abbott Plans to Spin Off $8.5 Billion Nutrition Business
The separation, targeted for the end of 2027, would leave Abbott with about $42 billion in annual sales from devices, diagnostics and established medicines.
Intuitive Q3 Revenue Rises 22% as $450 Million Antitrust Settlement Cuts Profit
The da Vinci maker placed 546 systems in the quarter and recorded a one-time charge to settle a class action, while planned instrument price cuts weighed on its shares.
Steris Agrees to Buy Pink Pad Maker Xodus Medical for $2.1 Billion
The sterilization company is adding operating room consumables, with up to $150 million more payable if Xodus hits 2028 targets.
Stryker to Invest About $400 Million in CMR Surgical, With Option to Buy
Stryker becomes the exclusive U.S. sales agent for CMR's Versius soft-tissue surgical robots and gains the right to acquire the whole company later.
GE HealthCare to Acquire SOFIE Biosciences for $945 Million in Cash
The deal would give GE HealthCare a U.S. network of 15 PET radiopharmaceutical manufacturing sites and the U.S. rights to a Phase III imaging agent.
iRhythm Completes VitalConnect Acquisition, Adding Mobile Cardiac Telemetry
The Zio maker paid $237.5 million in cash plus stock for the wearable biosensor company and will fold it into updated 2026 guidance on Nov. 5.
Integra LifeSciences Lowers 2026 Outlook After Cincinnati Plant Flooding
The company now expects 2026 revenue of $1.634 billion to $1.654 billion and says full manufacturing at the damaged site will not resume until the second quarter of 2027.
Terumo Neuro Agrees to Acquire Arsenal Medical, Developer of NeoCast Liquid Embolic
The neurovascular unit of Japan's Terumo did not disclose terms for the clinical-stage company, whose investigational embolic is in a pivotal trial for chronic subdural hematoma.
Precision Neuroscience Raises $250 Million Series D for Brain-Computer Interface
The round, co-led by Bill Ackman's Pershing Square and the Ackman Oxman Institute, brings the Layer 7 developer's total funding to $430 million.
Adagio Medical Explores Strategic Alternatives, Cuts 25 of Its 43 Jobs
The ventricular ablation developer, which reported about $7.7 million in cash at the end of June, says it will keep pursuing its pending FDA application for the vCLAS system.
Tandem Health Raises $100 Million Series B Led by EU-Backed Scaleup Europe Fund
The Stockholm company behind an AI medical assistant used in 14 European markets plans to build what it calls an AI-native clinic operating system.
Ambu Acquires Endoscopy Imaging Firm TIMS Medical for Up to $65 Million
The Danish single-use endoscope maker is paying $45 million upfront for the Massachusetts company and its base of about 7,000 U.S. hospital installations.
Axogen to Acquire NerveTape Maker BioCircuit Technologies for $200 Million
The peripheral nerve repair company plans to pay cash at closing, funded by a public stock offering announced the same day.
Boston Scientific Says Cyberattack Makes Its 2026 Sales and Profit Guidance Unlikely
A securities filing says the August incident will likely have a material impact on third-quarter and full-year results, with a revised outlook due on Oct. 28.
Medtronic Raises Fiscal 2027 Guidance After Q1 Revenue Grows 13.7%
Revenue reached $9.756 billion in a quarter that included an extra week, and the company announced about $780 million in investments in Cornerstone Robotics and Pi-Cardia.
Stryker Agrees to Acquire ZuriMED, Maker of FiberLocker Rotator Cuff Augmentation System
Terms were not disclosed for the deal, which Stryker says will strengthen its shoulder portfolio across sports medicine and arthroplasty.
Hike Medical Raises $22.5 Million to Expand From Custom Insoles Into Wider Medical Equipment
Saga Ventures led the seed and Series A funding for the San Francisco company, which pairs AI referral processing with an orthotics 3D printing lab in Peoria, Illinois.
Asker Healthcare Group Buys Baltic Medtech Distributor Ambercell Solutions
The Swedish group is taking all of the Lithuanian company, which supplies procedure packs and medical consumables to hospitals in Lithuania, Latvia and Estonia; no price was disclosed.
Renata Medical Closes $25 Million Series D Led by ARCHIMED for Pediatric Growth Stent
The Newport Beach company says the money will fund wider U.S. sales of its Minima stent, entry into international markets and more devices for children with congenital heart disease.
Bridge to Life Raises $110 Million in Equity and Debt for VitaSmart Liver Perfusion Rollout
Soleus Capital led the Series C equity and its credit fund supplied the debt; part of the money refinanced an existing loan from Perceptive Credit Funds.
Teledyne Agrees to Buy X-Ray Component Maker Varex Imaging for About $1.1 Billion
The all-cash deal, at $18.90 a share, would add X-ray tubes and photon counting detectors to Teledyne's imaging business; the companies expect it to close in early 2027.
Teleflex Completes $1.5 Billion Sale of OEM Business, Now Named Ingenyx
Montagu and Kohlberg relaunched the catheter and component maker as a standalone company, while Teleflex plans to use about $1.25 billion in after-tax proceeds on debt and buybacks.
KKR to Take Device Contract Manufacturer Integer Private in $5.7 Billion Deal
Integer stockholders would receive $127 a share in cash, ending a strategic review the Plano, Texas, company began in April.
GE HealthCare Reviews Options for Patient Care Unit as Q2 Orders Hit Record
Patient Care Solutions sales fell 13.3% and the segment lost money, while company-wide organic orders rose 11.1% and full-year guidance held.
MiMedx to Acquire Sanara MedTech in $350 Million Cash-and-Stock Deal
Sanara shareholders would receive $33 in cash plus MiMedx stock per share, a deal MiMedx says would nearly double its surgical revenue.
Edwards Lifesciences Raises 2026 Sales Outlook After Q2 TAVR Growth
Second-quarter sales rose 13.6% to $1.74 billion as Edwards awaits a Medicare coverage decision on TAVR expected in September.
Tempus to Acquire Cancer Test Maker Personalis in $1.5 Billion Deal
Tempus will pay $16.25 a share, mostly in stock, to bring the NeXT Personal minimal residual disease test it already distributes in-house.
Medtronic Completes $650 Million Acquisition of SPR Therapeutics
The all-cash deal adds SPR's 60-day SPRINT peripheral nerve stimulation system to Medtronic's neuromodulation pain portfolio.
J&J MedTech Sales Rise 4.5% as Cardiovascular Falls Short in Q2
Johnson & Johnson raised its 2026 outlook on a $25.3 billion quarter, but its medtech chief said cardiovascular growth was not where the company wanted it, with Abiomed sales down 2%.
Leo Cancer Care Raises $65 Million Series D for Upright Radiotherapy Platform
The Yu Galaxy-led round will fund manufacturing and commercial rollout of seated proton, photon and imaging systems, and comes with an unnamed strategic partnership.
Stereotaxis Completes Acquisition of French Robotics Developer Robocath
The St. Louis surgical robotics company now owns the maker of the R-One coronary robot, a deal it valued in April at $20 million upfront plus up to $25 million in milestone payments.